Swiss National Bank decreased its position in Cigna Corp. (NYSE:CI) by 0.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 746,974 shares of the company’s stock after selling 6,900 shares during the period. Swiss National Bank’s holdings in Cigna Corp. were worth $97,346,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Acrospire Investment Management LLC raised its position in Cigna Corp. by 166.7% in the second quarter. Acrospire Investment Management LLC now owns 800 shares of the company’s stock valued at $102,000 after buying an additional 500 shares during the period. Invictus RG raised its position in Cigna Corp. by 1,056.8% in the second quarter. Invictus RG now owns 1,018 shares of the company’s stock valued at $130,000 after buying an additional 930 shares during the period. M&R Capital Management Inc. bought a new position in Cigna Corp. during the second quarter valued at about $153,000. NEXT Financial Group Inc bought a new position in Cigna Corp. during the third quarter valued at about $168,000. Finally, First Financial Corp IN increased its position in Cigna Corp. by 11.0% in the third quarter. First Financial Corp IN now owns 1,316 shares of the company’s stock valued at $171,000 after buying an additional 130 shares in the last quarter. 84.62% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Cigna Corp. (NYSE:CI)

Cigna Corp. (NYSE:CI) opened at 136.77 on Tuesday. Cigna Corp. has a one year low of $115.03 and a one year high of $148.99. The stock has a market capitalization of $35.11 billion, a PE ratio of 18.59 and a beta of 0.50. The firm has a 50-day moving average of $128.01 and a 200-day moving average of $129.25.

Cigna Corp. (NYSE:CI) last released its earnings results on Thursday, November 3rd. The company reported $1.94 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.91 by $0.03. The company earned $9.90 billion during the quarter, compared to the consensus estimate of $4.37 billion. Cigna Corp. had a net margin of 4.87% and a return on equity of 16.17%. The company’s revenue was up 5.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.28 EPS. On average, equities research analysts forecast that Cigna Corp. will post $7.98 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Swiss National Bank Has $97,346,000 Stake in Cigna Corp. (CI)” was originally published by Financial Market News and is owned by of Financial Market News. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this story can be read at http://www.financial-market-news.com/swiss-national-bank-has-97346000-stake-in-cigna-corp-ci/1208307/.

Several equities analysts have issued reports on CI shares. Goldman Sachs Group Inc. restated a “buy” rating and issued a $160.00 price objective on shares of Cigna Corp. in a research note on Thursday, September 8th. Leerink Swann decreased their price objective on shares of Cigna Corp. from $160.00 to $155.00 and set an “outperform” rating for the company in a research note on Monday, August 1st. Zacks Investment Research upgraded shares of Cigna Corp. from a “sell” rating to a “hold” rating in a research note on Tuesday, October 4th. William Blair restated a “buy” rating on shares of Cigna Corp. in a research note on Wednesday, August 31st. Finally, Jefferies Group restated a “buy” rating on shares of Cigna Corp. in a research note on Tuesday, August 23rd. Six analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $156.00.

In related news, insider Jason D. Sadler sold 4,000 shares of the business’s stock in a transaction dated Monday, October 31st. The shares were sold at an average price of $121.80, for a total transaction of $487,200.00. Following the completion of the sale, the insider now owns 34,019 shares of the company’s stock, valued at approximately $4,143,514.20. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP John M. Murabito sold 58,822 shares of the business’s stock in a transaction dated Monday, November 7th. The shares were sold at an average price of $125.09, for a total transaction of $7,358,043.98. Following the sale, the executive vice president now directly owns 115,109 shares of the company’s stock, valued at approximately $14,398,984.81. The disclosure for this sale can be found here. 1.20% of the stock is currently owned by insiders.

Cigna Corp. Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.

5 Day Chart for NYSE:CI

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp. (NYSE:CI).

Receive News & Ratings for Cigna Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corp. and related companies with MarketBeat.com's FREE daily email newsletter.